These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 29162878

  • 21. Is there evidence for clinical differences related to the new classification of temporal lobe cortical dysplasia?
    Fauser S, Essang C, Altenmüller DM, Staack A, Steinhoff BJ, Strobl K, Bast T, Schubert-Bast S, Doostkam S, Zentner J, Schulze-Bonhage A.
    Epilepsia; 2013 May; 54(5):909-17. PubMed ID: 23551067
    [Abstract] [Full Text] [Related]

  • 22. Regulation of CBL and ESR1 expression by microRNA-22‑3p, 513a-5p and 625-5p may impact the pathogenesis of dust mite-induced pediatric asthma.
    Dong X, Xu M, Ren Z, Gu J, Lu M, Lu Q, Zhong N.
    Int J Mol Med; 2016 Aug; 38(2):446-56. PubMed ID: 27277384
    [Abstract] [Full Text] [Related]

  • 23. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
    Boer K, Lucassen PJ, Spliet WG, Vreugdenhil E, van Rijen PC, Troost D, Jansen FE, Aronica E.
    Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
    [Abstract] [Full Text] [Related]

  • 24. Reelin: a possible link between hippocampal sclerosis and cortical dyslamination in the setting of FCD type IIIa.
    Marucci G, Farnedi A, Giulioni M.
    Neurol Sci; 2012 Dec; 33(6):1479-81. PubMed ID: 22203331
    [Abstract] [Full Text] [Related]

  • 25. Short- and long-term surgical outcomes of temporal lobe epilepsy associated with hippocampal sclerosis: Relationships with neuropathology.
    Deleo F, Garbelli R, Milesi G, Gozzo F, Bramerio M, Villani F, Cardinale F, Tringali G, Spreafico R, Tassi L.
    Epilepsia; 2016 Feb; 57(2):306-15. PubMed ID: 26676889
    [Abstract] [Full Text] [Related]

  • 26. Focal cortical dysplasias in temporal lobe epilepsy surgery: Challenge in defining unusual variants according to the last ILAE classification.
    Martinoni M, Marucci G, Rubboli G, Volpi L, Riguzzi P, Marliani F, Toni F, Naldi I, Bisulli F, Tinuper P, Michelucci R, Baruzzi A, Giulioni M.
    Epilepsy Behav; 2015 Apr; 45():212-6. PubMed ID: 25812941
    [Abstract] [Full Text] [Related]

  • 27. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF, Brito JAR, Guimarães ALS, Gomes CC, de Lacerda JCT, de Castro WH, Coimbra RS, Diniz MG, Gomez RS.
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [Abstract] [Full Text] [Related]

  • 28. Microscopic mild focal cortical dysplasia in temporal lobe dual pathology: an electrocorticography study.
    Morales Chacón L, Estupiñán B, Lorigados Pedre L, Trápaga Quincoses O, García Maeso I, Sanchez A, Bender del Busto J, Garcia ME, Baez Martin M, Zaldivar M, Gómez A, Orozco S, Rocha Arrieta L.
    Seizure; 2009 Oct; 18(8):593-600. PubMed ID: 19679496
    [Abstract] [Full Text] [Related]

  • 29. Expression and cellular distribution of the interleukin 2 signaling system in cortical lesions from patients with focal cortical dysplasia.
    Guo W, Zheng DH, Sun FJ, Yang JY, Zang ZL, Liu SY, Yin Q, Zhang CQ, Yang H.
    J Neuropathol Exp Neurol; 2014 Mar; 73(3):206-22. PubMed ID: 24487795
    [Abstract] [Full Text] [Related]

  • 30. Transcriptomic profiling of high- and low-spiking regions reveals novel epileptogenic mechanisms in focal cortical dysplasia type II patients.
    Srivastava A, Kumar K, Banerjee J, Tripathi M, Dubey V, Sharma D, Yadav N, Sharma MC, Lalwani S, Doddamani R, Chandra PS, Dixit AB.
    Mol Brain; 2021 Jul 23; 14(1):120. PubMed ID: 34301297
    [Abstract] [Full Text] [Related]

  • 31. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
    Zhang J, Zhang Y, Shen W, Fu R, Ding Z, Zhen Y, Wan Y.
    Biomed Pharmacother; 2019 Sep 23; 117():109058. PubMed ID: 31176168
    [Abstract] [Full Text] [Related]

  • 32. SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients.
    Haenisch S, Zhao Y, Chhibber A, Kaiboriboon K, Do LV, Vogelgesang S, Barbaro NM, Alldredge BK, Lowenstein DH, Cascorbi I, Kroetz DL.
    Neurobiol Dis; 2015 May 23; 77():127-40. PubMed ID: 25766675
    [Abstract] [Full Text] [Related]

  • 33. Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II.
    Zhang Z, Liu Q, Liu M, Wang H, Dong Y, Ji T, Liu X, Jiang Y, Cai L, Wu Y.
    J Neuroinflammation; 2018 Jan 30; 15(1):27. PubMed ID: 29382328
    [Abstract] [Full Text] [Related]

  • 34. Genomic DNA methylation distinguishes subtypes of human focal cortical dysplasia.
    Kobow K, Ziemann M, Kaipananickal H, Khurana I, Mühlebner A, Feucht M, Hainfellner JA, Czech T, Aronica E, Pieper T, Holthausen H, Kudernatsch M, Hamer H, Kasper BS, Rössler K, Conti V, Guerrini R, Coras R, Blümcke I, El-Osta A, Kaspi A.
    Epilepsia; 2019 Jun 30; 60(6):1091-1103. PubMed ID: 31074842
    [Abstract] [Full Text] [Related]

  • 35. Serum MicroRNA-4521 is a Potential Biomarker for Focal Cortical Dysplasia with Refractory Epilepsy.
    Wang X, Sun Y, Tan Z, Che N, Ji A, Luo X, Sun X, Li X, Yang K, Wang G, Luan L, Liu Y, Wei M, Yin J.
    Neurochem Res; 2016 Apr 30; 41(4):905-12. PubMed ID: 26645999
    [Abstract] [Full Text] [Related]

  • 36. Clinicopathological associations in temporal lobe epilepsy patients utilising the current ILAE focal cortical dysplasia classification.
    Johnson AM, Sugo E, Barreto D, Cunningham AM, Hiew CC, Lawson JA, Somerville ER, Connolly AM, Bye AM.
    Epilepsy Res; 2014 Oct 30; 108(8):1345-51. PubMed ID: 25048307
    [Abstract] [Full Text] [Related]

  • 37. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
    Barros-Silva D, Costa-Pinheiro P, Duarte H, Sousa EJ, Evangelista AF, Graça I, Carneiro I, Martins AT, Oliveira J, Carvalho AL, Marques MM, Henrique R, Jerónimo C.
    Cell Death Dis; 2018 Feb 07; 9(2):167. PubMed ID: 29415999
    [Abstract] [Full Text] [Related]

  • 38. Pathology-Based Approach to Seizure Outcome After Surgery for Pharmacoresistant Medial Temporal Lobe Epilepsy.
    Martinoni M, Berti PP, Marucci G, Rubboli G, Volpi L, Riguzzi P, Marliani F, Toni F, Bisulli F, Tinuper P, Michelucci R, Baruzzi A, Giulioni M.
    World Neurosurg; 2016 Jun 07; 90():448-453. PubMed ID: 26968448
    [Abstract] [Full Text] [Related]

  • 39. Correlation Network Analysis Reveals Relationships between MicroRNAs, Transcription Factor T-bet, and Deregulated Cytokine/Chemokine-Receptor Network in Pulmonary Sarcoidosis.
    Dyskova T, Fillerova R, Novosad T, Kudelka M, Zurkova M, Gajdos P, Kolek V, Kriegova E.
    Mediators Inflamm; 2015 Jun 07; 2015():121378. PubMed ID: 26696750
    [Abstract] [Full Text] [Related]

  • 40. Type I focal cortical dysplasia: surgical outcome is related to histopathology.
    Tassi L, Garbelli R, Colombo N, Bramerio M, Lo Russo G, Deleo F, Milesi G, Spreafico R.
    Epileptic Disord; 2010 Sep 07; 12(3):181-91. PubMed ID: 20659869
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.